| Chapter 163 |
| 2021 -- S 0170 SUBSTITUTE B Enacted 07/02/2021 |
| A N A C T |
| RELATING TO INSURANCE -- PRESCRIPTION DRUG BENEFITS |
Introduced By: Senators Murray, McCaffrey, Miller, Goodwin, Mack, Lawson, Kallman, Bell, Valverde, and Goldin |
| Date Introduced: February 05, 2021 |
| It is enacted by the General Assembly as follows: |
| SECTION 1. Chapter 27-20.8 of the General Laws entitled "Prescription Drug Benefits" is |
| hereby amended by adding thereto the following section: |
| 27-20.8-3. Co-pay cap for prescription insulin. |
| (a) As used in this section, unless the context otherwise requires, "prescription insulin drug" |
| means a prescription drug, as defined in ยง 21-31-2, that contains insulin and is used to treat diabetes. |
| (b) A health plan that provides coverage for prescription insulin drugs pursuant to the terms |
| of a health coverage plan the health plan offers shall cap the total amount that a covered person is |
| required to pay for a covered prescription insulin drug at an amount not to exceed forty dollars |
| ($40.00), per thirty-(30) day (30) supply of insulin. Coverage for prescription insulin drugs shall |
| not be subject to any deductible. |
| (c) Nothing in this section prevents a health plan from reducing a covered person's cost |
| sharing to an amount less than the amount specified in subsection (b) of this section. |
| (d) The office of the health insurance commissioner may use any of its enforcement powers |
| to obtain a health plan's compliance with this section. |
| (e) The office of the health insurance commissioner may promulgate rules and regulations |
| as necessary to implement and administer this section and to align with federal requirements. |
| SECTION 2. This act shall take effect on January 1, 2022. |
| ======== |
| LC001009/SUB B |
| ======== |